Insider trades
Keith S. Manchester, Director of Roivant Sciences ROIV, has filed 0 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $154.5M. The latest trade was on 06/30.
Keith S. Manchester
Director
- Company
- Roivant Sciences ROIV
- First filing
- 23/05/26
- Trades
- 45 trades
- Buys / sales
- 0 / 27
- 12-month net buying
- −$154.5M
- Last trade
- 06/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ROIV | Open-market sale | 06/26–06/30 | 06/30 | 1,638,163 sh6 trades | $34.46avg. | $56,444,075.76 | No record |
ROIV | Open-market sale | 02/11–02/13 | 02/13 | 1,225,784 sh5 trades | $26.64avg. | $32,658,518.16 | −7.5% |
ROIV | Open-market sale | 25/12/16–25/12/17 | 25/12/18 | 1,694,614 sh5 trades | $23.05avg. | $39,065,213.44 | −9.4% |
ROIV | Open-market sale | 25/11/19 | 25/11/21 | 1,300,000 sh4 trades | $20.23avg. | $26,304,500 | −6.7% |
ROIV | Open-market sale | 24/09/24–24/09/25 | 24/09/26 | 503,000 sh2 trades | $11.67avg. | $5,868,782.72 | −28.3% |
| Open-market sale | 24/08/14 | 24/08/16 | 8,846 sh | $3.69 | $32,641.74 | −16.1% | |
ROIV | Open-market sale | 23/09/28 | 23/10/02 | 6,896,144 sh4 trades | $11.55avg. | $79,650,463.2 | −57.9% |
